A randomized, double-blind, placebo-controlled trial of naproxen with or without orphenadrine or methocarbamol for acute low back pain
Annals of Emergency Medicine Nov 03, 2017
Friedman BW, et al. - A comparison was performed of functional outcomes among patients randomized to a 1-week course of naproxen+placebo vs naproxen+orphenadrine or naproxen+methocarbamol for acute low back pain. Compared with naproxen+placebo, combining naproxen with either orphenadrine or methocarbamol did not improve functional outcomes among Emergency Department patients with acute, nontraumatic, nonradicular low back pain.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
